论文部分内容阅读
“在4月25日的”第二届中国医药互联网大会“上,艾美仕市场调研咨询(上海)有限公司政府事务部经理潘威就美国医疗APP的应用现状及相关启示作了演讲。”难以大面积开垦临床应用之地尽管发展迅猛,但移动App的兴起远未达到医疗健康服务供应的主流水平,仍然被认为是新颖的事物。根据imshealth对美国医疗App安装数据的统计分析,大概有57%的下载量少于500次,仅2%的App下载量超过10万次,有5个App下载量高达6.6亿人次,占15%。之所以出现上述情况,皆因为所有利益相关方
“On April 25 ” the Second China Medical Internet Conference “, Amy Shi Market Research Consulting (Shanghai) Co., Ltd. Government Department Manager Pan Wei on the status of the application of medical APP in the United States and related revelations Lecture. ”" It is difficult to reclaim clinical applications over large areas Despite the rapid growth, the rise of mobile apps is far from reaching the mainstream of healthcare delivery and is still considered novel. According to imshealth statistical analysis of the installation data of the United States medical applications, about 57% of the downloads less than 500 times, only 2% of the App downloads more than 100,000 times, 5 App downloads as high as 660 million passengers, accounting for 15% . This happens because all stakeholders